1. Home
  2. MD vs ZLAB Comparison

MD vs ZLAB Comparison

Compare MD & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pediatrix Medical Group Inc.

MD

Pediatrix Medical Group Inc.

N/A

Current Price

$25.91

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$25.88

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MD
ZLAB
Founded
1979
2013
Country
United States
China
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
MD
ZLAB
Price
$25.91
$25.88
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$20.50
$49.60
AVG Volume (30 Days)
638.9K
848.3K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
263.03
38.46
EPS
0.85
N/A
Revenue
$1,913,849,000.00
$460,156,000.00
Revenue This Year
$3.72
$9.75
Revenue Next Year
$2.62
$26.03
P/E Ratio
$31.21
N/A
Revenue Growth
N/A
15.33
52 Week Low
$15.70
$15.96
52 Week High
$28.86
$34.72

Technical Indicators

Market Signals
Indicator
MD
ZLAB
Relative Strength Index (RSI) 48.83 52.99
Support Level $25.24 $24.81
Resistance Level $27.23 $25.28
Average True Range (ATR) 0.79 0.76
MACD -0.04 -0.37
Stochastic Oscillator 53.81 35.75

Price Performance

Historical Comparison
MD
ZLAB

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: